
Menopause Hormone Therapy May Lower Alzheimer's Pathology, Stanford Study Shows
A Stanford Neurology study analyzing post-mortem and living participants found estrogen-only menopausal hormone therapy is associated with about a 35% lower risk of Alzheimer's pathology and 39% lower odds of dementia, with living users showing better memory and function. The work suggests possible neuroprotective effects of estrogen and potential greater benefit if started near menopause, but as an observational study it cannot prove causation, and randomized trials are needed to confirm brain-health benefits.








